Press releases
- Donaldson Foundation Announces Recipient of $100K Challenge Grant
- Donaldson Company, Inc., Through Its Univercells Technologies Business, Expands Their Relationship With the Gene Therapy Program at the University of Pennsylvania to Evaluate Certain Bioreactors for Scalable Gene Therapy Production
- Donaldson Company Announces Leadership Role Changes
- Donaldson Reports Record Third Quarter Fiscal Year 2024 Sales and Earnings
- Donaldson Company Increases Quarterly Cash Dividend 8.0%
- Donaldson to Present at the Stifel 2024 Cross Sector Insight and William Blair 44th Annual Growth Stock Conferences
- Donaldson Employees Recognized at May 13, 2024, Patent Recipient and Inventor Awards
- Donaldson and PolyPeptide Partner to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology
- Donaldson Announces Integrated Lentiviral Vector Manufacturing Platform Development
- Donaldson Company to Present at the Oppenheimer 19th Annual Industrial Growth Conference
More ▼
Key statistics
On Monday, Donaldson Company Inc (DNZ:DUS) closed at 66.50, -4.32% below its 52-week high of 69.50, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 65.50 |
---|---|
High | 66.50 |
Low | 65.50 |
Bid | -- |
Offer | -- |
Previous close | 66.50 |
Average volume | 0.20 |
---|---|
Shares outstanding | 120.41m |
Free float | 119.78m |
P/E (TTM) | 23.04 |
Market cap | 8.96bn USD |
EPS (TTM) | 3.23 USD |
Annual div (ADY) | 1.01 EUR |
---|---|
Annual div yield (ADY) | 1.54% |
Div ex-date | Jun 17 2024 |
Div pay-date | Jun 28 2024 |
Data delayed at least 15 minutes, as of Jul 22 2024 18:31 BST.
More ▼